Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model. 2005

A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
Department of Immunology, Institute Oswaldo Cruz, FIOCRUZ, Av. Brasil 4365, Rio de Janeiro RJ, CEP 21045-900, Brazil.

The antileishmanial efficacy of the reference drug N-methylglucamine antimoniate (Glucantime) was evaluated in groups of rhesus monkeys with acute and chronic Leishmania (Viannia) braziliensis cutaneous infection. The therapeutic responses in experimental animals to either a low dose (5 mg/kg body wt/day for 28 days) or a routine dose (20 mg/kg/day for 28 days) of pentavalent antimony were similar to those reported in the human disease. Primates were cured of their lesions after treatment, but with cryptic parasitism and/or relapse. The rhesus model of L. (V.) braziliensis cutaneous leishmaniasis therefore provides an additional resource for preclinical trials with newer drugs.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007892 Leishmania braziliensis A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana. Leishmania (Viannia) braziliensis,Leishmania braziliensis braziliensis,Leishmania (Viannia) brasiliensis,Leishmania brasiliensis,Leishmania brasiliensis brasiliensis,Leishmania brasiliensis peruviana,Leishmania braziliensis peruviana,Leishmania viannia brasiliensis,Leishmania viannia braziliensis
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000077485 Meglumine Antimoniate ANTIMONY salt of meglumine that is used in the treatment of LEISHMANIASIS. Glucantime,N-Methylglucamine Antimonate,N Methylglucamine Antimonate

Related Publications

A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
January 1976, Comparative biochemistry and physiology. A, Comparative physiology,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
March 1972, Experientia,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
August 1982, Laboratory animal science,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
January 1973, Journal of medical primatology,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
March 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
September 1969, Obstetrics and gynecology,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
November 2001, The American journal of tropical medicine and hygiene,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
January 2014, Biomedica : revista del Instituto Nacional de Salud,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
February 1977, Laboratory animal science,
A Teva, and R Porrozzi, and M P Oliveira-Neto, and G Júnior Grimaldi
January 2010, Tropical medicine & international health : TM & IH,
Copied contents to your clipboard!